Harrow (HROW) Times Interest Earned (2010 - 2026)
Harrow's (HROW) quarterly Times Interest Earned came in at -$1.4 in Q1 2026, down 518.12% year-on-year from $0.34 in Q1 2025, and down 310.01% quarter-over-quarter from $0.67 in Q4 2025.
Harrow (HROW) Times Interest Earned (2010 - 2026) Analysis & Trends
Harrow's Times Interest Earned history runs 17 years deep, the most recent figure standing at -$1.4 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 518.12% year-over-year to -$1.4 in Q1 2026; TTM through Mar 2026 was $1.25, a 1268.75% increase from a year earlier, with the FY2025 full-year figure at $0.48, up 261.86% from the prior year.
- Times Interest Earned retreated to -$1.4 in Q1 2026 per HROW's latest filing, from $0.67 in the prior quarter.
- Across five years, Times Interest Earned topped out at $16.26 in Q3 2025 and bottomed at -$1.4 in Q1 2026.
- The 5-year median for Times Interest Earned is $0.07 (2023), against an average of $1.06.
- Across the five-year window, Times Interest Earned sank 601.93% in 2024 and jumped 117820.91% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $0.4 in 2022, then sank by 159.95% to -$0.24 in 2023, then jumped by 846.37% to $1.78 in 2024, then plunged by 62.54% to $0.67 in 2025, then tumbled by 310.01% to -$1.4 in 2026.
- Per Business Quant, the three latest HROW Times Interest Earned figures stand at -$1.4 (Q1 2026), $0.67 (Q4 2025), and $16.26 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | -1.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | 16.26 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | -0.23 |
| Dec 31, 2024 | 1.78 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | -1.28 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.25 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.31 |
| Mar 31, 2022 | 1.17 |
| Dec 31, 2021 | -0.79 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | 0.36 |